Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, a new series of therapeutics that correct and potentiate some classes of mutations of the CFTR, have provided a great therapeutic advantage to people with cystic fibrosis (pwCF). The main hindrances of the present CFTR modulators...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Carla M. P., Higgs, Matthew G., Muhlebach, Marianne S., Wolfgang, Matthew C., Borgatti, Monica, Lampronti, Ilaria, Cabrini, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003689/
https://www.ncbi.nlm.nih.gov/pubmed/36902441
http://dx.doi.org/10.3390/ijms24055010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003689/
https://www.ncbi.nlm.nih.gov/pubmed/36902441
http://dx.doi.org/10.3390/ijms24055010

Ejemplares similares